Publications

Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study.

Taylor, SM; Parobek, CM; DeConti, DK; Kayentao, K; Coulibaly, SO; GREENWOOD, BM; Tagbor, H; Williams, J; BOJANG, K; NJIE, F; Desai, M; Kariuki, S; Gutman, J; Mathanga, DP; Mårtensson, A; Ngasala, B; Conrad, MD; Rosenthal, PJ; Tshefu, AK; Moormann, AM; Vulule, JM; Doumbo, OK; Ter Kuile, FO; Meshnick, SR; Bailey, JA; ... Juliano, JJ.

2014

The Journal of infectious diseases, (2014).211 5 10.1093/infdis/jiu467.

Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis.

Shrestha, S; KNIGHT, GM; Fofana, M; Cohen, T; WHITE, RG; Cobelens, F; Dowdy, DW;

2014

Open forum infectious diseases, (2014).1 2 10.1093/ofid/ofu073.

Increased Trypanosoma brucei cathepsin-L activity inhibits human serum-mediated trypanolysis.

ALSFORD, S;

2014

Microbial cell (Graz, Austria), (2014).1 8 10.15698/mic2014.08.162.

Independent origin of plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and Ethiopia.

Alifrangis, M; Nag, S; Schousboe, ML; Ishengoma, D; Lusingu, J; Pota, H; Kavishe, RA; Pearce, R; Ord, R; LYNCH, C; Dejene, S; COX, J; Rwakimari, J; Minja, DT R; Lemnge, MM; ROPER, C;

2014

Emerging infectious diseases, (2014).20 8 10.3201/eid2008.131897.

Molecular surveillance for artemisinin resistance in Africa.

ROPER, C; Alifrangis, M; Ariey, F; Talisuna, A; Menard, D; Mercereau-Puijalon, O; Ringwald, P;

2014

The Lancet infectious diseases, (2014).14 8 10.1016/S1473-3099(14)70826-6.

Introducing rapid diagnostic tests for malaria into drug shops in Uganda: design and implementation of a cluster randomized trial.

Mbonye, AK; Magnussen, P; CHANDLER, CI R; HANSEN, KS; LAL, S; CUNDILL, B; LYNCH, CA; CLARKE, SE;

2014

Trials, (2014).15 1 10.1186/1745-6215-15-303.

Genome evolution and plasticity of Serratia marcescens, an important multidrug-resistant nosocomial pathogen.

Iguchi, A; Nagaya, Y; Pradel, E; Ooka, T; Ogura, Y; Katsura, K; Kurokawa, K; Oshima, K; Hattori, M; Parkhill, J; Sebaihia, M; Coulthurst, SJ; Gotoh, N; THOMSON, NR; Ewbank, JJ; Hayashi, T;

2014

Genome biology and evolution, (2014).6 8 10.1093/gbe/evu160.

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.

Venkatesan, M; Gadalla, NB; Stepniewska, K; Dahal, P; Nsanzabana, C; Moriera, C; Price, RN; Mårtensson, A; Rosenthal, PJ; Dorsey, G; SUTHERLAND, CJ; Guérin, P; Davis, TM E; Ménard, D; Adam, I; Ademowo, G; Arze, C; Baliraine, FN; Berens-Riha, N; Björkman, A; Borrmann, S; CHECCHI, F; Desai, M; Dhorda, M; Djimdé, AA; ... Asaq Molecular Marker Study Group,

2014

The American journal of tropical medicine and hygiene, (2014).91 4 10.4269/ajtmh.14-0031.

Carriage of Staphylococcus aureus in Thika Level 5 Hospital, Kenya: a cross-sectional study.

AIKEN, AM; Mutuku, IM; Sabat, AJ; Akkerboom, V; Mwangi, J; SCOTT, JA G; Morpeth, SC; Friedrich, AW; Grundmann, H;

2014

Antimicrobial resistance and infection control, (2014).3 1 10.1186/2047-2994-3-22.

Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.

Kavishe, RA; Paulo, P; Kaaya, RD; Kalinga, A; Van Zwetselaar, M; Chilongola, J; ROPER, C; Alifrangis, M;

2014

Malaria journal, (2014).13 1 10.1186/1475-2875-13-264.